None listed
Conditions
Interventions
Medical Device : ESRD patients from age 19 to 74, undergoing living-donor or cadaverinc-donor kidney transplantation from from IRB approval to December 31, 2023 will be included in our study. The test
Sponsors
The Catholic University of Korea, Seoul St. Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Test group - Patients undergoing living-donor or cadaveric-donor kidney transplantation from IRB approval to December 31, 2023 at Seoul St. Mary's Hospital - Patients from age 19 to 74 - Patients with no exclusion criteria, and who have deciede to participate after informed consent 2. Control group - Patients who have undergone living-donor or cadaveric-donor kidney transplantation from January 1, 2018 to June 30, 2022 at Seoul St. Mary's Hospital - Patients from age 19 to 74
Exclusion criteria
Exclusion criteria: - Patients with a history of abdominal operation including extensive lymph node dissection - Patients who have undergone graft nephrectomy, due to acute rejection or bleeding, shortly after kidney transplantation. - Cases in which both ligasure ligation and hand-tie ligation were used during dissection - Patients with a mental condition - Patients unwilling to participate in the study - Other patients who are considered unfit to participate by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount discharge from surgical drain | — |
Secondary
| Measure | Time frame |
|---|---|
| Viscum album extract injection, Diagnosis of lymphocele | — |
Countries
Korea, Republic of
Contacts
Public ContactEunju Jang
The Catholic University of Korea, Seoul St. Mary's Hospital
Outcome results
None listed